GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More
Pfizer’s HYMPAVZI Wins Expanded EU Approval for Hardest-to-Treat Hemophilia Patients Who Had Almost No Options Left
The European Commission has expanded approval for Pfizer's hemophilia drug HYMPAVZI (marstacimab) to cover adolescents and adults with hemophilia A…
Read More
Drug Discovery Without Animal Trials, Better Nuclear Fuel, And Software For Military Planning
This is a monthly column that runs down five interesting startup funding deals every month that may have flown under…
Read More
Novartis CEO Narasimhan echoes call for EU drug pricing reform
Novartis CEO Vas Narasimhan states that Europe requireds a “complete reconsider” on how it prices its drugs, warning that the…
Read More
US pricing policy dents Europe drug launches: EU agency
European Medicines Agency Executive Director Emer Cooke speaks to Reuters European Pharmaceutical Correspondent Maggie Fick at Reuters Pharma 2026 in…
Read More
Sought-after Danish biotech secures head start with cancer drug candidate in the US
I want to receive customized email newsletters from Watch Medier A/S , including information about our brands and group companies…
Read More
Helsinki’s Algorithmiq wins €1.7 million prize for quantum-enabled light-sensitive cancer drug discovery
Algorithmiq, a Helsinki-based quantum software company, has become the sole winner of a €1.7 million ($2 million) prize from Wellcome…
Read More
Paris Prosecutors drop drug probe against French MEP Rima Hassan – POLITICO
She is due to stand trial on July 7 on charges that her post quoting Okamoto constitutes an apology for…
Read More
Drug manufacturing deals relocate to Europe despite pharma tariffs
Despite a federal push for onshoring and pharmaceutical import tariffs, biopharma companies have continued to increase their reliance on…
Read More
In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe
Last year saw the largest fall in US contract manufacturing (CM) deals for FDA-approved drugs in five years. Despite the…
Read More
